Cell Culture of Glioma Specimens for in Vitro Preclinical Studies
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01125826|
Recruitment Status : Unknown
Verified April 2009 by Albany Medical College.
Recruitment status was: Recruiting
First Posted : May 19, 2010
Last Update Posted : June 27, 2011
The purpose of this study is to culture primary human brain tumor cells with the specific aims of:
- Develop primary cultures from human brain tumor surgical specimens
- Determine the genetic and molecular fingerprints of brain tumors that may have prognostic significance
- Delineate the mechanisms underlying oncogenesis of brain tumors.
- Perform in vitro assays with brain tumor derived primary cultures to assess the efficacy of novel therapeutic agents.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Official Title:||Primary Cell Culture of Surgical Glioma Specimens for Invitro Preclinical Studies|
|Study Start Date :||April 2009|
|Estimated Primary Completion Date :||April 2012|
|Estimated Study Completion Date :||June 2012|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01125826
|Contact: Yu-Hung Kuo, MD||518 262 email@example.com|
|United States, New York|
|Albany Medical Center||Recruiting|
|Albany, New York, United States, 12208|
|Contact: Tyler Kenning, MD firstname.lastname@example.org|